Skip to content

Prophylactic glycopyrrolate reduces hypotensive responses in TURP patients during spinal anesthesia

Prophylactic glycopyrrolate reduces hypotensive responses in TURP patients during spinal anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20191105001
Enrollment
Unknown
Registered
2019-11-05
Start date
2019-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TURP surgery

Interventions

Fifty&#45
four patients older than 60 yr of age scheduled for TURP surgery with spinal anesthesia were included in the study. They received either glycopyrrolate 0.2 mg (group G) or normal saline (group C) intr
the ephedrine requirement&#44
mean arterial pressure&#44
total fluid&#44
total blood loss.,nomal saline 1.0 ml
glycopyrrolate 1.0 ml (0.2 mg),nomal saline 1.0 ml

Sponsors

Sawanpracharak Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: ASA II patient who has TURP surgery

Exclusion criteria

Exclusion criteria: glaucoma, hyperthyroid , cardiovascular disease, pulmonary disease , morbid obesity , renal or hepatic dysfunction , neuromuscular disease, coagulopathy used premedication in surgery day

Design outcomes

Primary

MeasureTime frame
Efficiency of glycopyrolate 0.2 mg during sugery until discharge cardiovascular effect

Secondary

MeasureTime frame
cardiovascular effect during sugery until discharge blood presure, heart rate, total fluid, total blood loss, total ephedrine use

Countries

Thailand

Contacts

Public ContactKamoltip Prasopsook

Sawanpracharak Hospital

kamolkate@hotmail.com0869231384

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026